These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 199129)

  • 21. A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics.
    Quitkin F; Rifkin A; Klein DF
    Psychopharmacol Bull; 1977 Jul; 13(3):27-9. PubMed ID: 329327
    [No Abstract]   [Full Text] [Related]  

  • 22. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.
    Knights A; Okasha MS; Salih MA; Hirsch SR
    Br J Psychiatry; 1979 Dec; 135():515-23. PubMed ID: 394794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia.
    Johnson DA; Malik NA
    Acta Psychiatr Scand; 1975 May; 51(4):257-67. PubMed ID: 1096536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics.
    Rifkin A; Quitkin F; Rabiner CJ; Klein DF
    Psychopharmacol Bull; 1976 Apr; 12(2):24-6. PubMed ID: 769022
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
    Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J
    Br J Psychiatry; 1991 May; 158():658-65. PubMed ID: 1860020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate.
    Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR
    Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks.
    Carpenter WT; Buchanan RW; Kirkpatrick B; Lann HD; Breier AF; Summerfelt AT
    Am J Psychiatry; 1999 Mar; 156(3):412-8. PubMed ID: 10080557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics.
    Quitkin F; Rifkin A; Kane J; Ramos-Lorenzi JR; Klein DF
    Arch Gen Psychiatry; 1978 Jul; 35(7):889-92. PubMed ID: 98127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.
    McClelland HA; Farquharson RG; Leyburn P; Furness JA; Schiff AA
    Arch Gen Psychiatry; 1976 Dec; 33(12):1435-9. PubMed ID: 11760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
    Dencker SJ; Frankenberg K; Malm U; Zell B
    Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
    [No Abstract]   [Full Text] [Related]  

  • 31. Aftercare of schizophrenic patients: pharmacotherapy and consistency of therapists.
    van der Kolk BA; Goldberg HL
    Hosp Community Psychiatry; 1983 Apr; 34(4):343-8. PubMed ID: 6132867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind trial of fluphenazine decanoate.
    Curry SH; Adamson L
    Lancet; 1972 Sep; 2(7776):543-4. PubMed ID: 4115602
    [No Abstract]   [Full Text] [Related]  

  • 34. Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia.
    MacCrimmon DJ; Saxena B; Foley P; Grof P
    Neuropsychobiology; 1978; 4(6):360-5. PubMed ID: 692838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
    Chouinard G; Annable L; Campbell W
    J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug and family therapy in the aftercare of acute schizophrenics.
    Goldstein MJ; Rodnick EH; Evans JR; May PR; Steinberg MR
    Arch Gen Psychiatry; 1978 Oct; 35(10):1169-77. PubMed ID: 211983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of depot neuroleptics: clinical experience in the United States.
    Kane JM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):5-12. PubMed ID: 6370987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Follow-up treatment of schizophrenic psychoses: advantages and disadvantages of long-term medication].
    Steuber H; Kind J; Lohrengel S; Müller P
    Arzneimittelforschung; 1978; 28(9):1492-3. PubMed ID: 38806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.